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ABSTRACT 
 
 The carotid body (CB) plays important roles in cardiorespiratory 
changes in intermittent hypoxia (IH). Erythropoietin (EPO), a hypoxia-
inducible factor (HIF)-1 target gene, is present in the chemoreceptive 
type-I cells in the CB but its expression and role in IH resembling sleep 
apnoeic conditions are not known. We hypothesized that IH upregulates 
the expression of EPO and its receptor (EPOr) in the rat CB. The CB 
expressions of EPO and EPOr were examined in rats breathing 10% O2 
(in isobaric chamber for CH, 24 hour/day) or in IH (cyclic between air 
and 5% O2 per minute, 8 hour/day) for 3-28 days. Immunohistochemical 
studies revealed that the EPO and EPOr proteins were localized in CB 
glomic clusters. The proportional amount of cells with positive staining 
of EPO immunoreactivities was significantly increased in both IH and 
CH groups when compared with the normoxic control. The EPO 
expression was more markedly increased in the CH than that of the IH 
groups throughout the time course, reaching a peak level at day 14. The 
positive EPOr immunostaining was increased significantly in the 3-day 
CH group. By day 14, the EPOr expression elevated considerably at 
peak levels in both IH and CH rats, whereas the elevation was greater in 
the CH rats. These results suggest an upregulation of EPO and its 
receptor expression in the rat CB under IH and CH conditions, 
presumably mediated by the activation of HIF-1 pathway. The increased 
EPO binding to its receptor might play a role in the enhancement of CB 
excitability during the early pathogenesis in patients with sleep-
disordered breathing. 
 
1.    INTRODUCTION 
 
Carotid body (CB) plays important roles in cardiorespiratory 
changes in both chronic hypoxia (CH) and intermittent hypoxia (IH) 
(Gonzalez et al. 1994; Prabhakar 2001). During CH, the hypertrophy and 
hyperplasia of CB glomus cells contribute to the CB enlargement as 
observed in high altitude dwellings and patients with chronic obstructive 
EPO and EPOr expression in CB during CH and IH 
pulmonary disease (Bee and Howard 1993; Heath et al. 1970). Under IH 
conditions, hypoxic chemosensitivity and the ventilatory chemoreflex 
were significantly augmented in the rat CB (Peng et al. 2004). Also, IH 
enhances the hypoxia-evoked neurotransmitter release from the CB as 
well as PC12 cells (Kim et al. 2004). 
Hypoxia-inducible factor (HIF)-1α plays a physiological role in 
CH and IH. The expression of HIF-1α and the transcriptional regulation 
of an array of HIF-regulated genes in the rat CB is an essential 
molecular mechanism for the structural remodelling and functional 
changes of the organ under hypoxic conditions (Lam et al. 2008; 
Prabhakar 2001). Upregulation of the HIF-regulated genes such as 
vascular endothelial growth factor (VEGF), VEGF receptors, 
endothelin-1 and tyrosine hydroxylase are crucial for the CB response to 
hypoxic conditions (Chen et al. 2002; Fung 2003; Lam et al. 2008; 
Tipoe and Fung 2003).  
Erythropoietin (EPO), a HIF-regulated gene, despite its novel 
erythropoietic function in enhancing red blood cells production, has 
been shown to modulate the ventilatory response to reduced oxygen 
supply mediated by activation of CB chemoreceptors. In fact, the CB 
was proposed to be an endocrine gland participating in the control of 
erythropoiesis (Tramezzani et al. 1971). Recent study has demonstrated 
that exogenous EPO could activate the CB chemoreceptor during CH. In 
addition, EPO receptor (EPOr) was found to be present in the 
chemoreceptive type-I cells in the CB (Soliz et al. 2005). Furthermore, 
high EPO plasma levels could modulate the CB chemotransduction in 
CH (Soliz et al. 2007). However, the expression and role of EPO under 
IH resembling sleep apnoeic conditions are unclear. It is hypothesized 
that the expression of EPO and its receptor (EPOr) in the rat CB could 
be regulated by CH or IH. The aim of the present study was to examine 
the CB expressions of EPO and EPOr in rats breathing 10% O2 for CH 
or in cyclic O2 levels between 5-21% for IH for 3-28 days. Our results 
suggest an upregulation of EPO and its receptor expression in the rat CB 
under IH and CH conditions, presumably mediated by the activation of 
HIF-1 pathway.  
 
2.    METHODS 
The experimental protocol for this study was approved by the 
Committee on the Use of Live Animals in Teaching and Research of 
The University of Hong Kong. Male Sprague-Dawley rats aged 28 days 
were randomly divided into groups for the treatment of CH or IH and for 
normoxic (Nx). While the Nx controls were kept in room air with the 
same housing and maintenance, both CH and IH rats were kept in acrylic 
chambers for normobaric hypoxia and had free access to water and chow 
(Tipoe and Fung 2003). The oxygen fraction inside the chamber was 
kept at 10 + 0.5%, 24 h per day for the CH group and was cyclic from 
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21 to 5 + 0.5% per min, 60 cycles / h, 8 h per day diurnally for the IH 
group in which the inspired oxygen level fell to 4-5% (nadir arterial 
oxygen saturation ca. 70%) for about 15 sec per min, which mimicks the 
recurrent episodic hypoxemia in patients with obstructive sleep apnoea 
(Fletcher 2001). The desired oxygen level was established by a mixture 
of room air and nitrogen that was regulated and monitored by an oxygen 
analyzer (Vacumetrics Inc., CA, USA). Carbon dioxide was absorbed by 
soda lime granules and excess humidity was removed by a desiccator. 
The chamber was opened twice a week for an hour to clean the cages 
and replenish food and water. The rats were exposed to hypoxia for 3, 14 
and 28 days and were immediately used in experiments after taken out 
of the chambers. 
 Following deep anesthesia with halothane, the rat was 
decapitated and the carotid bifurcation was excised rapidly. The CB was 
carefully dissected free from the bifurcation and was fixed in neutral 
buffered formalin for 72 hour. Tissues were processed routinely for 
histology and embedded in paraffin blocks. Serial sections of 5 μm 
thickness were cut and mounted on silanized slides (DAKO, Denmark). 
Sections were kept in the oven overnight at 56oC. Consequently, 
sections were deparaffinized, rehydrated and immunostained with 
antiserum to the following proteins: EPO (rabbit IgG antibody, 1:500 
dilution, Cat # E0271, Sigma, USA); EPOr (goat IgG antibody, 1:500 
dilution, Cat # E4644, Sigma, USA), using LSAB kit (K0690, DAKO). 
In brief, sections were immersed in antigen retrieval solution (0.1 M 
citric acid buffer, pH 6.0) for 10 min at 98oC. To block endogenous 
peroxidase activity, the sections were immersed in 3% hydrogen 
peroxide for 5 min at room temperature. All sections were immersed in a 
solution containing 0.01% trypsin and calcium chloride for 5 min at 
room temperature and were pre-incubated with 20% normal serum for 2 
hour to reduced non-specific binding for the antiserum. Then sections 
were incubated with the corresponding primary antibodies in 0.05 M 
Tris-HCl buffer, respectively, containing 2% bovine serum albumin 
overnight at 4oC. Sections were washed three times in PBS, and then 
incubated with biotinylated link agent and streptavidin peroxidase for 30 
min at room temperature. Finally, sections were washed and the 
peroxidase was visualized by immersing in 0.05% diaminobenzidine 
containing 0.03% H2O2 in Tris-HCl buffer (pH 7.5). Sections were 
counterstained mildly with hematoxylin. Control sections were prepared 
by substitution of primary antibodies with buffer or normal serum, and 
liquid phase pre-adsorption of the used antibodies with excess blocking 
peptides (Sigma, USA). 
 The immunoreactivities of EPO and EPOr were measured using 
the Leica QWIN Imager Analyzer (Cambridge, UK).  Immunostained 
sections were captured with a CCD JVC camera using a Zeiss Axiophot 
microscope at 100X objective. The luminance incident light passing 
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through each section was calibrated using the set-up menu where the 
grey pixel values were set to 0 and 1.00. Once the setup was done, five 
fields per section from one CB of one animal were measured. The 
percent area of positive stain for both EPO and EPOr protein was 
measured by detecting the positive brown cytoplasmic stain divided by 
the sum areas of the reference field. A total of 20 fields for 4 CBs from 
four different animals at each time-point namely day 3, 14 and 28 were 
determined. The mean value of the 20 fields was calculated to represent 
each time-point. 
GraphPad Prism® software (GraphPad Software, Inc., San Diego, 
USA) was used to analyze the data.  A non-parametric Mann-Whitney 
U-test was used to compare differences between time-points. A p-value 
< 0.05 was considered statistically significant. 
 
3.    RESULTS 
 
Immunohistochemical studies revealed that the EPO and EPOr 
proteins were positively stained in most of cells throughout the CBs of 
rats exposed to CH and IH treatment (n=5). The positive staining of 
EPO and EPOr were localized in CB glomic clusters (Figs 1A and 2A). 
Moreover, the immunostaining was not observed in the CB of the 
corresponding control sections incubated with normal serum instead of 
the primary antibodies (data not shown). 
The proportional amount of cells with positive staining of EPO 
immunoreactivities (IR) was significantly increased in both IH and CH 
groups when compared with the Nx control. The EPO expression was 
markedly increased in the 3-day group of both IH and CH rats, while the 
elevation was less in IH than CH. A sustained significant increase of 
EPO expression was found throughout the time course and reached a 
peak level at day 14 in both IH and CH rats, but augmented in a greater 
extent in CH than IH (Fig. 1B). 
The positive staining of EPOr expression was markedly 
increased in the 3-day groups of CH rats. By day 14, the EPOr 
expression elevated considerably and reached a peak level in both the IH 
and CH rats, whereas the elevation was greater in CH than IH. Moreover, 
EPOr expression reduced to levels above the Nx control in the CH group 
but remained elevated in IH by day 28 (Fig. 2B). 
As reported previously, positive staining of HIF-1α in the rat CB 
is significantly more in the CH, but not in the IH group (Fig. 3 modified 
from (Lam et al. 2008)). Collectively, these results suggest an 
upregulation of the expression of EPO and its receptor in the rat CB 
under IH and CH conditions, presumably mediated by the activation of 
HIF-1 pathway. These observations are consistent with the hypothesis 
that EPO plays a functional role in the enhancement of CB excitability 
under hypoxic conditions. 
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4.    DISCUSSION 
 
EPO acts as a key regulator of erythropoiesis, by promoting the 
survival and proliferation of erythroid precursor cells (Jelkmann 1992). 
The kidney produces EPO in response to hypoxia, and thereby increases 
the number of red blood cells in order to increase the tissue oxygen 
supply (Pagel et al. 1992). Evidence suggest that the CB is an endocrine 
gland playing a part in the control of erythropoiesis despite its classical 
chemoreceptive function (Tramezzani et al. 1971). The present study 
demonstrated that (1) EPO and its receptors, EPOr were expressed and 
localized in CB glomic clusters; (2) The proportional amount of cells 
with positive staining of EPO and EPOr immunoreactivities were 
significantly increased in both IH and CH groups when compared with 
the Nx control. These findings unequivocally support the hypothesis that 
CH and IH upregulate the EPO and its receptor expression in the rat CB. 
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Figure 1.  A: Immunohistochemical localization of EPO in 3-, 14-, and 28-day treatment 
of IH, CH and their corresponding Nx in rat CB. Bar = 40 μm. B. Protein expressions of 
EPO in carotid body of rat in Nx, IH and CH for 3 (D3), 14 (D14) and 28 days (D28). 
Data are presented in % area with positive staining of EPO immunoreactivity and are 
expressed as mean + SEM (n=5 for each group).  
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Figure 2.  A: Immunohistochemical localization of EPOr in 3-, 14- and 28-day treatment 
of IH, CH and their corresponding Nx in rat CB.  Bar = 40 μm. B: Protein expressions of 
EPOr in carotid body of rat in Nx, IH and CH for 3 (D3), 14 (D14) and 28 days (D28). 
Data are presented in % area with positive staining of EPOr immunoreactivity and are 
expressed as mean + SEM (n=5 for each group). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  Protein expressions of HIF-1α in the carotid body of rat in Nx, IH and CH for 
3 (D3), 14 (D14) and 28 days (D28). Data are presented in % nuclei with positive 
staining of HIF-1α immunoreactivity and are expressed as mean + SEM (n=5 for each 
group). Adapted and modified from Lam et al., Histol Histopathol (2008) 23:271-280. 
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Physiological responses to hypoxia involve changes in gene 
expression that are mediated by the transcriptional activator HIF-1. As 
cellular oxygen concentration decreases, expression of HIF-1α increases 
exponentially with the upregulation of various proteins such as EPO to 
exert the physiological effects  (Wang et al. 1995). Along with the 
presence and upregulation of HIF-1α in the nuclei of the CB in hypoxia, 
it has been demonstrated that EPO is indeed expressed in the CB glomus 
cells and its expression is increased in CH and IH. Our study showed 
that the expression was more markedly increased in the CH than that of 
the IH groups throughout the time course, reaching a peak level at day 
14. The differential expression of HIF-1α in CH and IH might account 
for the expression profile of EPO under two different hypoxic conditions. 
Nonetheless, elevated EPO expression observed in the CB during CH 
and IH might contribute to the activation of the peripheral 
chemoreceptors in CB and the modulation of the CB chemotransduction 
in hypoxia.  
EPO has been shown to modulate the ventilatory response to 
reduced oxygen supply despite its novel erythropoietic function in 
enhancing red blood cells production. Recent study has showed that 
exogenous EPO activates the peripheral chemoreceptor in CH. The 
expression of EPOr in the medullary respiratory centre as well as in the 
CB chemosensitive type-I cells suggests that EPO could modulate the 
hypoxic ventilatory response at both the central and peripheral levels 
(Soliz et al. 2005; Soliz et al. 2007). In agreement, our results 
demonstrated that EPOr was expressed in the CB glomus cells and the 
expression was upregulated by both CH and IH. Thus, the positive EPOr 
immunostaining was increased significantly in the 3-day CH group and 
was elevated considerably at peak levels by day 14 in both the IH and 
CH rats with a greater extent of elevation in the CH group. This 
expression profile is in conjunction to the HIF-1α expression in the CB, 
although the EPOr expression was partially returned to the Nx level at 
day 28.  
In summary, these results suggest an upregulation of the 
expression of EPO and its receptor in the CB glomic clusters in the CH 
and IH rats. The increased EPO expression in the CB may be mediated 
by the activation of HIF-1 pathway under hypoxic conditions. It is 
speculated that the increased expression of EPO and its receptor might 
be functionally related to the augmented CB hypoxic chemosensitivity 
and ventilatory chemoreflex under CH and IH conditions, which are 
relevant to the physiological acclimation to high altitude and the 
pathophysiological changes in patients with sleep-disordered breathing.  
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